Johnson & Johnson (NYSE:JNJ) announced today that it entered into a definitive agreement to acquire Atraverse Medical. Atraverse develops the Hotwire transseptal access system, a novel radiofrequency guidewire left-heart access device. It enables zero-exchange left-heart access while acting as a rail for catheter-based therapy systems. … [Read more...] about Johnson & Johnson to acquire AtraVerse Medical and its transseptal access system
Atraverse Medical
The biggest cardiac tech news out of the 2026 AF Symposium
Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium. At the event, the makers of technologies like pulsed field ablation (PFA) systems, left atrial appendage (LAA) devices, heart access catheters and more offered insights into how their therapies contribute to the treatment … [Read more...] about The biggest cardiac tech news out of the 2026 AF Symposium
Atraverse reports positive data for Hotwire transseptal access system
Atraverse Medical today announced new clinical and preclinical data supporting its Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It enables zero-exchange left-heart access while acting as a rail for catheter-based therapy systems. Steven Mickelsen, a pioneer in the pulsed field ablation … [Read more...] about Atraverse reports positive data for Hotwire transseptal access system
Atraverse wins FDA clearance for left heart access device
Atraverse Medical announced today that it received FDA clearance for its fully integrated Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It enables zero exchange left-heart access while acting as a rail for catheter-based therapy systems. Steven Mickelsen, a pioneer in the pulsed field … [Read more...] about Atraverse wins FDA clearance for left heart access device
Atraverse raises $29.4M for left-heart access device
Atraverse Medical announced today that it closed a $29.4 million follow-on financing round to help accelerate growth. The San Diego-based company secured an oversubscribed seed funding round worth $12.5 million last year. This follow-on funding builds on that round, which helped to obtain FDA 510(k) clearance and begin the early rollout of … [Read more...] about Atraverse raises $29.4M for left-heart access device
Atraverse wins FDA nod for left-heart access device, raises $12.5M
Atraverse Medical announced today that the FDA cleared its Hotwire radiofrequency guidewire left-heart access device. The novel device enables zero exchange left-heart access while acting as a rail for catheter-based therapy systems. Steven Mickelsen, the founder of Farapulse, invented the Hotwire system with co-founder Eric Sauter. It's the … [Read more...] about Atraverse wins FDA nod for left-heart access device, raises $12.5M
